Cite
Gurnari C, Pagliuca S, Guan Y, et al. TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Blood Adv. 2022;6(1):100-107doi: 10.1182/bloodadvances.2021005418.
Gurnari, C., Pagliuca, S., Guan, Y., Adema, V., Hershberger, C. E., Ni, Y., Awada, H., Kongkiatkamon, S., Zawit, M., Coutinho, D. F., Zalcberg, I. R., Ahn, J. S., Kim, H. J., Kim, D. D. H., Minden, M. D., Jansen, J. H., Meggendorfer, M., Haferlach, C., Jha, B. K., Haferlach, T., Maciejewski, J. P., & Visconte, V. (2022). TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Blood advances, 6(1), 100-107. https://doi.org/10.1182/bloodadvances.2021005418
Gurnari, Carmelo, et al. "TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes." Blood advances vol. 6,1 (2022): 100-107. doi: https://doi.org/10.1182/bloodadvances.2021005418
Gurnari C, Pagliuca S, Guan Y, Adema V, Hershberger CE, Ni Y, Awada H, Kongkiatkamon S, Zawit M, Coutinho DF, Zalcberg IR, Ahn JS, Kim HJ, Kim DDH, Minden MD, Jansen JH, Meggendorfer M, Haferlach C, Jha BK, Haferlach T, Maciejewski JP, Visconte V. TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. Blood Adv. 2022 Jan 11;6(1):100-107. doi: 10.1182/bloodadvances.2021005418. PMID: 34768283; PMCID: PMC8753204.
Copy
Download .nbib
